Cookie Img
+919665797395
Home » Products » Pharmaceutical Medicine » Prograf

Prograf

Prograf
Prograf
Product Code : Pr
Brand Name : Prograf
Product Specifications
  • Formulations Type
  • General Drugs
  • Formulations Form
  • Capsules
  • Gender/Age Group
  • Suitable For All Ages
  • Storage Instructions
  • Store in Cool
Trade Information
  • Minimum Order Quantity
  • 10
  • Unit of Measure
  • Piece/Pieces
  • Payment Terms
  • Telegraphic Transfer (T/T), Western Union, Others
  • Supply Ability
  • 100000 Per Day
  • Delivery Time
  • 7-8 Days
  • Sample Available
  • Yes
  • Sample Policy
  • Within a certain price range free samples are available
  • Packaging Details
  • 1*10 BLISTER PACK
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • Certifications
  • FDA APPROVED
Product Description

Prograf is the medicine with active ingredient Tacrolimus. Tacrolimus is also manufactured by differ manufacturers and sold in differ countries under the trade names Advagraf, Fujimycin, Prograf, Protopic. All these medicines are original brand name medicines or pharmaceutical analogues.

Prograf therapy requires careful monitoring by adequately qualified and equipped personnel. The medicinal product should only be prescribed, and changes in immunosuppressive therapy initiated, by physicians experienced in immunosuppressive therapy and the management of transplant patients.

Inadvertent, unintentional or unsupervised switching of immediate- or prolonged-release formulations of tacrolimus is unsafe. This can lead to graft rejection or increased incidence of side effects, including under- or over-immunosuppression, due to clinically relevant differences in systemic exposure to tacrolimus. Patients should be maintained on a single formulation of tacrolimus with the corresponding daily dosing regimen; alterations in formulation or regimen should only take place under the close supervision of a transplant specialist (see sections 4.4 and 4.8). Following conversion to any alternative formulation, therapeutic drug monitoring must be performed and dose adjustments made to ensure that systemic exposure to tacrolimus is maintained. 




MEDIFLORA PHARMACY

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



MEDIFLORA PHARMASI All Rights Reserved.